
chemotherapy breast cancer 
majority cancer patients 
referred chemotherapy far advanced 
stages disease.  difficulty deliver- 
ing effective dose oncolytic agent 
involved areas may limit results 
treatment unless patient's tumor un- 
usually responsive one.  variability re- 
sponse apparently similar cases 
cancer cell type become in- 
creasingly evident, puzzling 
fact 20 per cent patients breast 
cancer will live 5 years treatment.  
decisions choice chemother- 
apy hormone therapy, well 
choice chemotherapeutic agent 
employed, may difficult. 
experience increases, usefulness 
chemotherapy treatment cancer 
becoming increasingly apparent.  also be- 
come apparent chemotherapy 
regarded curative procedure advanced 
cancer even though occasional patient ap- 
pears cured.  however, value 
oncolytic agents prolonging useful 
survival time, ameliorating many dis- 
tressing symptoms associated cancer, 
providing physician extra tool 
positive program care cancer 
patient now established. 
